Leukotriene A4 hydrolase: The janus enzyme shows its ugly side in smokers

American Journal of Respiratory and Critical Care Medicine

Volumn 190, Issue 1, 2014, Pages 5-7

  Snelgrove, Robert ^a   Kheradmand, Farrah ^b   DeBakey, Michael E ^c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACROLEIN; CIGARETTE SMOKE; LEUKOTRIENE A4 HYDROLASE; EPOXIDE HYDROLASE;

ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; EDITORIAL; EMPHYSEMA; HUMAN; LUNG LAVAGE; LYMPHOCYTE ACTIVATION; MACROPHAGE; MEMORY T LYMPHOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION; IMMUNOLOGY; LUNG; PATHOPHYSIOLOGY;

EPOXIDE HYDROLASES; HUMANS; LUNG; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 84903833062     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201405-0975ED     Document Type: Editorial

References (15)

1. Kheradmand F, Shan M, Xu C, Corry DB. Autoimmunity in chronic obstructive pulmonary disease: clinical and experimental evidence. Expert Rev Clin Immunol 2012;8: 285-292.
2. Xu C, Hesselbacher S, Tsai CL, Shan M, Spitz M, Scheurer M, Roberts L, Perusich S, Zarinkamar N, Coxson H, et al. Autoreactive t cells in human smokers is predictive of clinical outcome. Front Immunol 2012;3: 267.
3. Weathington NM, van Houwelingen AH, Noerager BD, Jackson PL, Kraneveld AD, Galin FS, Folkerts G, Nijkamp FP, Blalock JE. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med 2006;12: 317-323.
4. O'Reilly P, Jackson PL, Noerager B, Parker S, Dransfield M, Gaggar A, Blalock JE. N-Alpha-PGP and PGP, potential biomarkers and therapeutic targets for COPD. Respir Res 2009;10: 38.
5. O'Reilly PJ, Jackson PL, Wells JM, Dransfield MT, Scanlon PD, Blalock JE. Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations. BMJ Open 2013;3: e004140.
6. Braber S, Koelink PJ, Henricks PA, Jackson PL, Nijkamp FP, Garssen J, Kraneveld AD, Blalock JE, Folkerts G. Cigarette smoke-induced lung emphysema in mice is associated with prolyl endopeptidase, an enzyme involved in collagen breakdown. Am J Physiol Lung Cell Mol Physiol 2011;300: L255-L265.
7. Snelgrove RJ, Jackson PL, Hardison MT, Noerager BD, Kinloch A, Gaggar A, Shastry S, Rowe SM, Shim YM, Hussell T, et al. A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation. Science 2010;330: 90-94.
8. 4 hydrolase-proline-glycine-proline pathway in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2014;190: 51-61.
9. Hardison MT, Brown MD, Snelgrove RJ, Blalock JE, Jackson P. Cigarette smoke enhances chemotaxis via acetylation of prolineglycine-proline. Front Biosci (Elite Ed) 2012;4: 2402-2409.
10. Orning L, Fitzpatrick FA. Modification of leukotriene A(4) hydrolase/aminopeptidase by sulfhydryl-blocking reagents: differential effects on dual enzyme activities by methylmethane thiosulfonate. Arch Biochem Biophys 1999;368: 131-138.
11. Zheng JP, Wen FQ, Bai CX, Wan HY, Kang J, Chen P, Yao WZ, Ma LJ, Li X, Raiteri L, et al.; PANTHEON study group. Twice daily N-Acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial. Lancet Respir Med 2014;2: 187-194.
12. Zheng JP, Kang J, Huang SG, Chen P, Yao WZ, Yang L, Bai CX, Wang CZ, Wang C, Chen BY, et al. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study. Lancet 2008;371: 2013-2018.
13. Beeh KM, Kornmann O, Buhl R, Culpitt SV, Giembycz MA, Barnes PJ. Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. Chest 2003;123: 1240-1247.
14. van Houwelingen AH, Weathington NM, Verweij V, Blalock JE, Nijkamp FP, Folkerts G. Induction of lung emphysema is prevented by L-Arginine-Threonine- Arginine. FASEB J 2008;22: 3403-3408.
15. 4 hydrolase aminopeptidase in the pathogenesis of emphysema. J Immunol 2014;192: 5059-5068.